Warning letter
Nurse Assist, Inc: warning letter of May 8, 2017
FDA warning letter 524298 · Dallas District Office
Key facts
| Reference number | 524298 |
|---|---|
| Company | Nurse Assist, Inc |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | May 8, 2017 |
| Posted date | Dec 19, 2017 |
| Issuing office | Dallas District Office |
| Product type | Devices |
| CFR sections cited | 820 |
| Inspection city | Haltom City |
| Inspection ZIP | 76117 |
| Inspection start date | Oct 12, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: